Icon

NAPRELAN (nda020353)- (EQ 375MG BASE,EQ 500MG BASE,EQ 750MG BASE)

NAPROXEN SODIUM TWI PHARMS
EQ 375MG BASE,EQ 500MG BASE,EQ 750MG BASE
Yes Yes
2014-Jun-10 Expired
None None
None No
NAPRELAN is a nonsteroidal anti-inflammatory drug indicated for the treatment of: • rheumatoid arthritis (RA) • osteoarthritis (OA) • ankylosing spondylitis (AS) • tendinitis, bursitis • acute gout • primary dysmenorrhea (PD) • the relief of mild to moderate pain
1 0 1
Total Other Developers 12
Drugs with Suitability No
EQ 375MG BASE ** ** - - -
EQ 500MG BASE ** ** - - 1
EQ 750MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* **** ** *** ****** ****** ******* ******* *********** **** **. **-*-*, ***** ** ***** ********** ******, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.